U.S. MARKETS FOR INCONTINENCE MANAGEMENT PRODUCTS

253 Pages | 88 Exhibits | 2002 Analysis | Forecasts Through 2006 Product Family: Market Reports




OVERVIEW:
Urinary incontinence (UI) affects approximately 15 million Americans. Total sales of products used in the diagnosis and treatment of UI were estimated at $1.37 billion in 2001. Due to the size of both current and potential UI markets, medical professionals and product manufacturers have placed significant emphasis on research into the diagnosis and treatment of this condition, which has resulted in the development of several new therapies and approaches that could potentially delay UI symptoms for years in some patients and even cure others.

This report from Medtech Insight includes analyses of technologies, products, current and forecast markets, competitors, and opportunities in the incontinence management products market.

Major topics include: bone anchor and fixation systems; diagnostic ultrasound systems; nerve stimulation devices; pelvic muscle rehabilitation systems; periurethral bulking agents; radiofrequency bladder neck suspension systems; sling procedure products; urethral prostheses & inserts; urinary incontinence pharmaceuticals; and urodynamic measurement systems.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Types of Urinary Incontinence
ii. Urinary Incontinence Caseload
iii. Urinary Incontinence Management Products Markets
	a. Diagnostic Products Market
	b. Medical Management Products Market
	c. Therapeutic Devices Market

Exhibit ES-1: Forms of Urinary Incontinence 
Exhibit ES-2: Urinary Incontinence, Caseload Forecast, 2000-2006 
Exhibit ES-3: Female Urinary Incontinence, Caseload Forecast, by Type, 2000-2006 
Exhibit ES-4: Urinary Incontinence Management Products, Market Forecast, 2000-2006 
Exhibit ES-5: Products Utilized in the Diagnosis of Urinary Incontinence, Market Forecast, 2000-2006 
Exhibit ES-6: Urinary Incontinence Pharmaceuticals, Market Forecast, 2000-2006 
Exhibit ES-7: Urinary Incontinence Therapeutic Devices, Market Forecast, 2000-2006 
Exhibit ES-8: Pelvic Muscle Rehabilitation Devices, Market Forecast, 2000-2006 
Exhibit ES-9: Male External Catheter Systems and Related Products, Market Forecast, 2000-2006 
Exhibit ES-10: Prosthetic Slings, Market Forecast, 2000-2006 
Exhibit ES-11: Bone Anchors and Fixation Systems, Market Forecast, 2000-2006 
Exhibit ES-12: Tension-Free Vaginal Tape (TVT) and TVT-Like Products, Market Forecast, 2000-2006 
Exhibit ES-13: Radiofrequency Bladder Neck Suspension Products, Market Forecast, 2000-2006 
Exhibit ES-14: Artificial Urinary Sphincter Devices, Market Forecast, 2000-2006 
Exhibit ES-15: Periurethral Bulking Agents, Market Forecast, 2000-2006 
Exhibit ES-16: Urethral Prostheses and Inserts, Market Forecast, 2000-2006 
Exhibit ES-17: Sacral Nerve Stimulation Devices Used in the Treatment of Urinary Incontinence, Market Forecast, 2000-2006 
Exhibit ES-18: Extracorporeal Magnetic Innervation Products, Market Forecast, 2000-2006 
 
1. URINARY INCONTINENCE OVERVIEW

1.1 Types of Urinary Incontinence
	1.1.1 Stress Urinary Incontinence
	1.1.2 Urge Incontinence
	1.1.3 Mixed Incontinence
	1.1.4 Overflow Incontinence
	1.1.5 Other Types of Incontinence
1.2 Providers and Sites for Incontinence Diagnosis and Treatment
1.3 Urinary Incontinence Caseload Forecast

Exhibit 1-1: Forms of Urinary Incontinence 
Exhibit 1-2: Types of Stress Urinary Incontinence 
Exhibit 1-3: Urinary Incontinence, Caseload Forecast, 2000-2006 
Exhibit 1-4: Female Urinary Incontinence, Caseload Forecast, by Type, 2000-2006 
 
2. DIAGNOSTIC PRODUCTS MARKET

2.1 Basic Urinary Incontinence Evaluation
	2.1.1 Patient History
	2.1.2 Physical Examination
	2.1.3 Post-Void Residual Volume Measurement
	2.1.4 Urinalysis
	2.1.5 Other Tests
2.2 Specialized Urinary Incontinence Testing
	2.2.1 Urodynamic Studies
		2.2.1.1 Products         
		2.2.1.2 Procedure Volumes
	2.2.2 Cystoscopy
		2.2.2.1 Products
		2.2.2.2 Procedure Volumes
	2.2.3 Imaging Studies
		2.2.3.1 Products
		2.2.3.2 Procedure Volumes
	2.2.4 Market Analysis
		2.2.4.1 Urodynamic Measurement Systems
			2.2.4.1.1 Market Forecast
			2.2.4.1.2 Competitive Analysis
		2.2.4.2 Cystoscopes
			2.2.4.2.1 Market Forecast
			2.2.4.2.2 Competitive Analysis
		2.2.4.3 Office-Based Diagnostic Ultrasound Systems
			2.2.4.3.1 Market Forecast
			2.2.4.3.2 Competitive Analysis

Exhibit 2-1: Agency for Health Care Policy and Research Guidelines for Incontinence--Criteria for Further Evaluation of Incontinence Patients 
Exhibit 2-2: Types of Tests Utilized in the Performance of Urodynamic Studies 
Exhibit 2-3: 2002, Selected Urodynamics Measurement Systems 
Exhibit 2-4: 2000, Urodynamic Study Procedures, by Type and Site 
Exhibit 2-5: Urodynamics Studies, Procedure Volumes Forecast, 2000-2006 
Exhibit 2-6: Diagnostic Cystoscopy in Men, Procedure Volumes Forecast, 2000-2006 
Exhibit 2-7: 2002, Selected Office-Based Diagnostic Ultrasound Systems 
Exhibit 2-8: Office-Based Diagnostic Ultrasound Evaluations for Urologic Conditions, Procedure Volumes Forecast, 2000-2006 
Exhibit 2-9: Products Utilized in the Diagnosis of Urinary Incontinence, Market Forecast, 2000-2006 
Exhibit 2-10: Urodynamic Measurement Products, Market Forecast, 2000-2006 
Exhibit 2-11: Urodynamic Measurement Systems, Market Forecast, 2000-2006 
Exhibit 2-12: Urodynamic Measurement Consumables, Market Forecast, 2000-2006 
Exhibit 2-13: 2001, Urodynamic Measurement Products Market, Share by Supplier 
Exhibit 2-14: Rigid and Flexible Cystoscopes, Market Forecast, 2000-2006 
Exhibit 2-15: 2001, Rigid and Flexible Cystoscopes Market, Share by Supplier 
Exhibit 2-16: Office-Based Diagnostic Ultrasound Systems, Market Forecast, 2000-2006 
Exhibit 2-17: Office-Based Diagnostic Transrectal Ultrasound Systems, Market Forecast, 2000-2006 
Exhibit 2-18: Office-Based Diagnostic Obstetric/Gynecology Ultrasound Systems, Market Forecast, 2000-2006 
Exhibit 2-19: 2001, Office-Based Diagnostic Ultrasound Systems, Share by Supplier
 
3. MEDICAL MANAGEMENT PRODUCTS MARKET

3.1 Behavioral Therapies
	3.1.1 Toileting Assistance
	3.1.2 Bladder Training
	3.1.3 Pelvic Muscle Exercises
3.2 Drug Therapy
	3.2.1 Drug Therapy Options for Urge Incontinence
		3.2.1.1 Anticholinergics/Antispasmodics
			3.2.1.1.1 Detrol/Detrol LA
			3.2.1.1.2 Ditropan XL
			3.2.1.1.3 Other Drugs with Anticholinergic/Antispasmodic Effects
		3.2.1.2 Tricyclics
		3.2.1.3 Calcium Channel Blockers
	3.2.2 Drug Therapy Options for Stress Urinary Incontinence
		3.2.2.1 Alpha-Adrenergic Agonists
		3.2.2.2 Estrogen
	3.2.3 Drug Therapy Options for Overflow Incontinence
		3.2.3.1 Alpha-Adrenergic Antagonists
		3.2.3.2 Cholinergic Agonists
	3.2.4 Urinary Incontinence Drug Therapies in Development
		3.2.4.1 Capsaicin
		3.2.4.2 Darifenacin
		3.2.4.3 DPI-221
		3.2.4.4 Duloxetine Hydrochloride
		3.2.4.5 HCT-1026
		3.2.4.6 IGF-1
		3.2.4.7 KW-7158
		3.2.4.8 Resiniferatoxin
		3.2.4.9 (S)-Oxybutynin
		3.2.4.10 Trospium Chloride
		3.2.4.11 YM905
		3.2.4.12 ZD 0947
		3.2.4.13 Other Approaches
	3.2.5 Urinary Incontinence Drug Delivery Methods in Development
		3.2.5.1 Localized Drug Delivery
		3.2.5.2 Controlled-Release Delivery
		3.2.5.3 Transdermal Delivery
	3.2.6 Market Forecast
	3.2.7 Competitive Analysis

Exhibit 3-1: Medical Management Options for the Treatment of Urinary Incontinence 
Exhibit 3-2: Urge Incontinence Drug Therapy, Caseload Forecast, 2000-2006 
Exhibit 3-3: 2002, Selected Urinary Incontinence Drug Therapy Products in Development 
Exhibit 3-4: 2002, Selected Urinary Incontinence Drug Delivery Methods in Development 
Exhibit 3-5: Urinary Incontinence Pharmaceuticals, Market Forecast, 2000-2006 
Exhibit 3-6: Detrol, Market Forecast, 2000-2006 
Exhibit 3-7: Ditropan XL, Market Forecast, 2000-2006 
Exhibit 3-8: Standard Urinary Incontinence Pharmaceuticals, Market Forecast, 2000-2006 
Exhibit 3-9: New Urinary Incontinence Pharmaceuticals, Market Forecast, 2000-2006 
Exhibit 3-10: 2001, Urinary Incontinence Pharmaceuticals, Share by Supplier
 
4. THERAPEUTIC DEVICES MARKET

4.1 Pelvic Muscle Rehabilitation Products
	4.1.1 Biofeedback Therapy
	4.1.2 Vaginal Weight Training
	4.1.3 Pelvic Floor Electrical Stimulation
	4.1.4 Market Analysis
4.2 Male External Catheter Systems and Related Products
	4.2.1 Market Analysis
4.3 Urinary Incontinence Surgery Treatments and Products
	4.3.1 Treatments to Correct Bladder Neck Hypermobility
		4.3.1.1 Retropubic Urethropexy
		4.3.1.2 Transvaginal Needle Bladder Neck Suspension
		4.3.1.3 Anterior Vaginal and Abdominal Paravaginal Repairs
		4.3.1.4 Radiofrequency Bladder Neck Suspension
	4.3.2 Treatments to Correct Intrinsic Sphincter Deficiency
		4.3.2.1 Sling Procedures
		4.3.2.2 Tension-Free Vaginal Tape Procedure
		4.3.2.3 Artificial Urinary Sphincter Devices
	4.3.3 Treatments for Detrusor Instability
		4.3.3.1 Augmentation Intestinocystoplasty
		4.3.3.2 Urinary Diversion
	4.3.4 Treatments to Remove Outlet Obstruction
	4.3.5 Surgery Enhancement Products
		4.3.5.1 Bone Anchors and Fixation Systems
		4.3.5.2 Sling Materials and Products
		4.3.5.3 Tension-Free Vaginal Tape Alternatives
	4.3.6 Stress Urinary Incontinence Surgery Products
		4.3.6.1 Sling Materials, Market Analysis
		4.3.6.2 Bone Anchors and Fixation Systems, Market Analysis
		4.3.6.3 Tension-Free Vaginal Tape (TVT) and TVT-Like Products, Market Analysis
		4.3.6.4 Radiofrequency Bladder Neck Suspension Systems, Market Analysis
		4.3.6.5 Artificial Urinary Sphincter Devices, Market Analysis
4.4 Periurethral Bulking Agents
	4.4.1 Coaptite
	4.4.2 Contigen
	4.4.3 Cymetra
	4.4.4 Deflux
	4.4.5 Durasphere
	4.4.6 Engineered Collagen Fibrils
	4.4.7 Hylagel Uro
	4.4.8 Macroplastique
	4.4.9 Microspheres
	4.4.10 Silk-Elastin Polymer Urethral Bulking Agent
	4.4.11 UroVive
	4.4.12 Uryx
	4.4.13 Market Analysis
4.5 Urethral Prostheses and Inserts
	4.5.1 Control
	4.5.2 On-Command
	4.5.3 OPTION-v
	4.5.4 Impress Softpatch
	4.5.5 FemSoft Urethral Assist Female Continence Insert
	4.5.6 In-Flow
	4.5.7 Market Analysis
4.6 Nerve Stimulators
	4.6.1 Interstim
	4.6.2 Stoller Afferent Nerve Stimulation System
	4.6.3 NeoControl
	4.6.4 Market Analysis

Exhibit 4-1: Urinary Incontinence Therapeutic Devices, Market Forecast, 2000-2006 
Exhibit 4-2: 2002, Selected Pelvic Muscle Rehabilitation Products 
Exhibit 4-3: Pelvic Muscle Rehabilitation Devices, Market Forecast, 2000-2006 
Exhibit 4-4: 2001, Pelvic Muscle Rehabilitation Devices Market, Share by Supplier 
Exhibit 4-5: Male External Catheter Systems and Related Products, Market Forecast, 2000-2006 
Exhibit 4-6: 2001, Male External Catheter Systems and Related Products Market, Share by Supplier 
Exhibit 4-7: Available Surgical Treatment Options for the Correction of Bladder Neck Hypermobility 
Exhibit 4-8: Available Surgical Treatment Options for the Correction of Intrinsic Sphincter Deficiency 
Exhibit 4-9: Male and Female Intrinsic Sphincter Deficiency 
Exhibit 4-10: The Advantages of Utilizing Suburethral Slings Over Artificial Urinary Sphincters in the Treatment of Post-Prostatectomy Urinary Incontinence 
Exhibit 4-11: Comparative Outcomes for Stress Urinary Incontinence Surgical Procedures 
Exhibit 4-12: The Functioning of the Surgically Implanted Artificial Urinary Sphincter Device 
Exhibit 4-13: Artificial Urinary Sphincters, Implantations Forecast, 2000-2006 
Exhibit 4-14: 2002, Selected Bone Anchors and Fixation Systems 
Exhibit 4-15: 2002, Selected Sling Materials 
Exhibit 4-16: Stress Urinary Incontinence Surgery Products, Market Forecast, 2000-2006 
Exhibit 4-17: Prosthetic Slings, Market Forecast, 2000-2006 
Exhibit 4-18: 2001, Prosthetic Slings Market, Share by Supplier 
Exhibit 4-19: Bone Anchors and Fixation Systems, Market Forecast, 2000-2006 
Exhibit 4-20: 2001, Bone Anchors and Fixation Systems Market, Share by Supplier 
Exhibit 4-21: Tension-Free Vaginal Tape (TVT) and TVT-Like Products, Market Forecast, 2000-2006 
Exhibit 4-22: 2001, Tension-Free Vaginal Tape (TVT) and TVT-Like Products Market, Share by Supplier 
Exhibit 4-23: Radiofrequency Bladder Neck Suspension Products, Market Forecast, 2000-2006 
Exhibit 4-24: Radiofrequency Bladder Neck Suspension Generators, Market Forecast, 2000-2006 
Exhibit 4-25: Radiofrequency Bladder Neck Suspension Disposables, Market Forecast, 2000-2006 
Exhibit 4-26: Artificial Urinary Sphincter Devices, Market Forecast, 2000-2006 
Exhibit 4-27: 2002, Selected Periurethral Bulking Agents in Development 
Exhibit 4-28: Periurethral Bulking Agents, Market Forecast, 2000-2006 
Exhibit 4-29: Contigen, Market Forecast, 2000-2006 
Exhibit 4-30: New Periurethral Bulking Agents, Market Forecast, 2000-2006 
Exhibit 4-31: 2001, Periurethral Bulking Agents, Share by Supplier 
Exhibit 4-32: 2002, Selected Urethral Prostheses and Inserts 
Exhibit 4-33: Urethral Prostheses and Inserts, Market Forecast, 2000-2006 
Exhibit 4-34: 2001, Urethral Prostheses and Inserts, Share by Supplier 
Exhibit 4-35: 2002, Selected Nerve Stimulation Devices for the Treatment of Urinary Incontinence 
Exhibit 4-36: Sacral Nerve Stimulation Devices Used in the Treatment of Urinary Incontinence, Market Forecast, 2000-2006 
Exhibit 4-37: Extracorporeal Magnetic Innervation Products, Market Forecast, 2000-2006 
 
5. COMPANY PROFILES

5.1 ALZA Corporation/Johnson & Johnson
5.2 American Medical Systems, Inc.
5.3 C.R. Bard, Inc.
5.4 Boston Scientific Corporation
5.5 Carbon Medical Technologies, Inc.
5.6 Circon Corporation
5.7 Cook Inc./CookGroup
5.8 Hollister, Inc.
5.9 Johnson & Johnson
5.10 Laborie Medical Technologies Corporation
5.11 Life-Tech, Inc.
5.12 Mentor Corporation
5.13 Neotonus, Inc.
5.14 Olympus America, Inc./Olympus Group
5.15 Pharmacia Corporation
5.16 Rochester Medical Corporation
5.17 Karl Storz Endoscopy-America, Inc./Karl Storz GmbH & Co. KG
 
COMPANY LISTING


COMPANIES COVERED:

  1. ALZA Corporation/Johnson & Johnson
  2. American Medical Systems, Inc.
  3. C.R. Bard, Inc.
  4. Boston Scientific Corporation
  5. Carbon Medical Technologies, Inc.
  6. Circon Corporation
  7. Cook Inc./CookGroup
  8. Hollister, Inc.
  9. Johnson & Johnson
  10. Laborie Medical Technologies Corporation
  11. Life-Tech, Inc.
  12. Mentor Corporation
  13. Neotonus, Inc.
  14. Olympus America, Inc./Olympus Group
  15. Pharmacia Corporation
  16. Rochester Medical Corporation
  17. Karl Storz Endoscopy-America, Inc./Karl Storz GmbH & Co. KG
Contact Us

Need help finding medtech research? Let us help you!